Prot #KCP-330-009: A Phase 2b Open-label, Randomized Two-arm Study of Selinexor (KPT-330) with Low Dose Dexamethasone in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)

Project: Research project

Project Details

StatusFinished
Effective start/end date12/23/14 → 12/23/20

Funding

  • Clinipace, Inc. (Prot #KCP-330-009)
  • Karyopharm Therapeutics Inc. (Prot #KCP-330-009)